
Sign up to save your podcasts
Or
Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 15 minutes long and presents 5-6 recently published articles from ADA journals.
Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting.
This month we review articles on:
1. Glargine U-300 vs Glargine U-100
2. Accuracy of Blood Glucose Monitors 3. Time to Start and Intensify Medications
4. Hypoglycemia and Death in the LEADER Trial
5. Empagliflozin and Fracture Risk
6. Empagliflozin and Non-alcoholic Fatty Liver
For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org.
Presented by:
Neil S. Skolnik, M.D., Professor of Family and Community Medicine, Temple University School of Medicine; Associate Director, Family Medicine Residency Program, Abington Memorial Hospital.
John J. Russell, M.D., Associate Professor of Family and Community Medicine, Temple University School of Medicine; Director, Family Medicine Residency Program, Abington Memorial Hospital.
4.5
8585 ratings
Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 15 minutes long and presents 5-6 recently published articles from ADA journals.
Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting.
This month we review articles on:
1. Glargine U-300 vs Glargine U-100
2. Accuracy of Blood Glucose Monitors 3. Time to Start and Intensify Medications
4. Hypoglycemia and Death in the LEADER Trial
5. Empagliflozin and Fracture Risk
6. Empagliflozin and Non-alcoholic Fatty Liver
For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org.
Presented by:
Neil S. Skolnik, M.D., Professor of Family and Community Medicine, Temple University School of Medicine; Associate Director, Family Medicine Residency Program, Abington Memorial Hospital.
John J. Russell, M.D., Associate Professor of Family and Community Medicine, Temple University School of Medicine; Director, Family Medicine Residency Program, Abington Memorial Hospital.
128 Listeners
317 Listeners
481 Listeners
690 Listeners
283 Listeners
252 Listeners
3,326 Listeners
90 Listeners
1,094 Listeners
695 Listeners
174 Listeners
511 Listeners
320 Listeners
413 Listeners
363 Listeners